IMCAS World 2027: scientific congress and exhibition

28–30 January 2027 · Palais des Congrès de Paris, Paris, France · in person and online. IMCAS World is an international congress focused on dermatology, plastic surgery, aesthetic medicine and longevity science. Its programme brings scientific lectures, live procedure showcases and interactive workshops together with an exhibition for medical-industry companies. The 2027 event description highlights regenerative therapies, advanced energy-based devices and AI-enhanced treatment planning. The organiser says more than 20,000 participants are expected. Check the current programme and speaker information for confirmed sessions and updates.

Why IMCAS Paris matters

Connect evidence with clinical decisions

Use scientific sessions to distinguish established findings from emerging approaches and identify what still needs review before it informs practice.

Compare approaches across specialties

Dermatology, plastic surgery and aesthetic medicine overlap without sharing every clinical objective. A multidisciplinary congress can expose you to different ways of framing a clinical question; keep your speciality, scope and professional responsibilities central.

Assess technology in context

The event highlights regenerative therapies, energy-based devices and AI-enhanced treatment planning. Use exhibition conversations to ask about intended use, evidence, technical requirements, limitations and support. A product presentation is a starting point, not a substitute for independent clinical and regulatory review.

Who should visit IMCAS Paris?

Arrive with a clear professional question. These priorities reflect the congress’s documented subjects and audiences.

Dermatologists and aesthetic physicians

Review clinical developments, compare evidence around emerging techniques and assess how devices or treatment-planning tools may relate to your work. Identify patient-care questions before selecting sessions; separate established evidence from early findings and note what needs follow-up.

Plastic and reconstructive surgeons

Follow scientific discussion across surgery and aesthetic medicine, compare approaches with other specialties and examine technology relevant to your practice. Ask about intended use, supporting evidence, training and limitations rather than relying on broad promotional claims.

Researchers, educators and clinical faculty

Track research questions and areas where evidence and real-world application need closer examination. Note methods and references, distinguish findings from interpretation, and use peer discussions to identify unanswered questions for further work.

Medical-technology and aesthetic-medicine companies

Define whether your objective is product visibility, technical feedback, professional discussion or market learning. Prepare accurate information about indications, evidence, technical requirements and regulatory status. Exhibition participation does not guarantee buyer access or commercial results.

Clinic owners and clinical decision-makers

Bring questions about clinical need, intended users, training, maintenance, evidence and implementation. Treat congress exposure as an input to internal evaluation, not proof that a product is suitable for your clinic or patients.

What can you explore at IMCAS Paris?

Dermatology, plastic surgery and aesthetic medicine

These are core subjects in the congress identity. Use the programme to locate sessions and speakers aligned with your speciality and clinical interests. Consult the live programme for confirmed topics rather than assuming a specific procedure will be covered.

Longevity science and emerging technologies

The 2027 description names regenerative therapies, energy-based devices and AI-enhanced treatment planning. Connect each theme to a practical question: intended application, available evidence, patient or workflow context, technical requirements, risks and limitations. Verify individual exhibitors and products in the current catalogue.

Scientific lectures, showcases and workshops

The organiser describes lectures, live procedure showcases and interactive workshops. Check the current programme for named sessions, speakers and participation conditions. A demonstration can illustrate a technique but does not by itself establish comparative effectiveness or suitability for a particular patient.

What makes IMCAS Paris different?

The congress combines scientific content with a medical-aesthetics exhibition. The 2027 description links research and clinical application with regenerative therapies, energy-based devices and AI-enhanced treatment planning. Clinicians can move between scientific discussion and questions about practical tools; researchers and companies can hear how clinical priorities are framed. Evaluate those perspectives critically: scientific findings, demonstrations and commercial material serve different purposes and are not interchangeable evidence.

Set a useful objective before you go

If you are a clinician

Leave with an evidence map for one clinical question. Identify relevant sessions, record the source and quality of evidence discussed, and list what remains to be reviewed.

If you are a researcher or educator

Identify two or three questions for further study or clearer teaching. Note methods, references and where evidence is still developing.

If you represent a company

Test whether your product explanation answers clinicians’ questions. Prepare concise information on intended use, evidence, technical requirements and regulatory status; define appropriate follow-up.

If you lead a clinic or team

Build an evaluation checklist for a technology or training need. Record clinical fit, training, maintenance, evidence and internal review requirements before making a decision.

How to prepare for IMCAS Paris

1. Define the question you want answered

Choose one primary objective and up to two secondary ones, such as understanding evidence for a clinical approach, comparing technology against a defined need or identifying research themes. A focused objective makes a large multidisciplinary programme easier to navigate.

2. Review the programme and speaker information

The official programme page links a PDF programme and speaker information. Identify sessions that directly address your question, then check the organiser’s materials again before travelling because details can change.

3. Build a shortlist

Mark essential sessions A, useful alternatives B and optional discoveries C. If the current product catalogue or congress map is available, use it to identify relevant exhibitors and plan a manageable route. Confirm current versions and access requirements.

4. Prepare clinical and technical questions

For a technique, ask what evidence supports it and what limitations apply. For a device, ask about intended use, indications, training, maintenance, performance evidence and regulatory status. For AI-supported planning, ask what data it uses, how outputs are validated and where professional judgement remains essential.

5. Confirm registration and participation details

The organiser provides a registration route and advertises in-person and online participation. Check current access options, fees, deadlines, cancellation terms and any requirements for sessions you plan to attend.

6. Set a follow-up system

Use a note template: session or company → key point → evidence or specification to verify → relevance to my work → next action. Keep research findings, supplier claims and your own interpretation separate.

How to make the most of the congress

Use the programme as a decision tool, not an obligation to attend everything. After each session, record the clinical question, evidence presented and what remains uncertain. In exhibition conversations, explain your professional context and ask focused questions. Request relevant technical or clinical material for later review, and avoid sharing confidential patient information or making commitments without authority.

Take time to consolidate notes and adjust your plan. If a session or conversation runs long, drop a lower-priority item rather than rushing through everything. A small set of well-understood findings is more useful than a pile of unreviewed brochures.

Beyond the exhibition floor

The event description names scientific lectures, live procedure showcases and interactive workshops, while the programme page provides speaker information and a PDF programme. Check it for confirmed sessions. When reviewing a showcase, consider the context and stated limitations; a demonstration does not alone establish effectiveness or suitability. Follow up on evidence, safety, training and professional requirements.

Networking with a purpose

Prepare a short introduction describing your role and the issue you are exploring. Clinicians may bring a practice question, researchers a method or evidence gap, and companies a precise explanation of product relevance. At the end of a useful discussion, agree on an appropriate next step, such as reviewing technical documentation or checking a research reference. Record context as well as names; no particular connection or business result is guaranteed.

Plan your participation realistically

IMCAS World 2027 spans three days, with in-person and online participation advertised. One day may suit visitors with a defined specialty focus; several days may help those combining sessions across specialties, workshops and exhibition conversations. Confirm the access format that fits your objectives.

The event is at the Palais des Congrès de Paris. Consult the official trip-planning information for current venue guidance. Transport schedules, parking, accommodation and daily opening hours were not established here; verify them before travel.

Who should consider exhibiting?

The organiser presents exhibition and sponsorship opportunities for medical-aesthetics companies. The 2027 exhibitor page says booth space is sold out and directs interested companies to a waitlist. Check current availability, eligibility and terms. Companies considering future participation should define a business objective, present supportable claims, and be ready to discuss intended use, evidence, safety and regulatory status. Exhibition presence does not guarantee sales or clinical adoption.

After IMCAS Paris: turn information into decisions

Sort notes into three groups: A — act now: references, documents or internal discussions tied to your objective; B — evaluate: ideas needing evidence, budget or regulatory review; C — monitor: topics not yet relevant to an immediate decision.

Verify references before changing practice. Compare device specifications, evidence, training and service requirements with actual needs. Researchers should follow up on methods and open questions; companies should send only requested information and keep agreed actions explicit.

IMCAS Paris visitor checklist

Before

• ☐ Define a clinical, research or commercial objective.
• ☐ Review the current programme, speakers and participation information.
• ☐ Prioritise sessions and confirm the directory or map.
• ☐ Prepare evidence, device or research questions.
• ☐ Confirm registration, access format and travel requirements.
• ☐ Set up a note and follow-up system.

During

• ☐ Separate session claims from your interpretation.
• ☐ Note evidence, intended use, limitations and open questions.
• ☐ Ask suppliers for technical and regulatory information.
• ☐ Protect patient confidentiality.
• ☐ Reassess priorities rather than rushing to cover everything.

After

• ☐ Verify references and claims before practice or purchasing decisions.
• ☐ Sort contacts by a clear next action.
• ☐ Share concise findings with relevant colleagues.
• ☐ Follow up on material that supports your objective.

Is IMCAS Paris worth attending?

IMCAS Paris is most relevant to clinicians, researchers and medical-industry professionals working across dermatology, plastic surgery, aesthetic medicine or longevity science. Its value is strongest when you use the scientific programme to examine evidence and the exhibition to ask precise questions about relevant technologies. The multidisciplinary format can broaden perspectives, but only if you filter sessions and claims through your professional needs. Without a question and a follow-up plan, the scale of a large congress can make it difficult to turn activity into a useful decision.

IMCAS Paris 2027 at a glance

Make your IMCAS Paris visit purposeful

Ask: What clinical, research or business question do I want to answer—and what evidence would make the answer useful? Use the congress to learn, compare and follow up with care: Question. Examine. Verify. Decide.

Medical aesthetics and medical-device opportunities in France

Market size and demand

France’s medical-device industry recorded €35.7 billion in turnover in 2025, according to Snitem, the French medical-technology industry association, which published the figure in September 2026. Snitem reports that the total was 9.2% higher than in 2023. This is an industry-wide measure, not a market-size estimate for aesthetic procedures or devices. It signals a substantial medtech ecosystem but does not establish demand, market share or sales potential for an IMCAS product category.

Market drivers and commercial opportunities

The available data describe the broad medical-device sector rather than aesthetic-medicine demand. Manufacturers and suppliers of technologies relevant to dermatology may investigate how documented intended use and evidence fit the French and wider European clinical context. Buyers and clinic decision-makers could compare technologies and identify technical, evidence and service questions for later evaluation. Segment demand and commercial returns should be verified independently.

Regulations and market-entry conditions

France’s health regulator ANSM describes medical-device market access as governed by a European framework. Manufacturers must demonstrate applicable health and safety conformity; CE marking indicates conformity. Depending on risk class, a notified body may assess the device and manufacturer quality system. Manufacturers remain responsible for monitoring performance and safety after placing a device on the market. Requirements depend on product classification and intended purpose, so verify current obligations with competent authorities and qualified regulatory specialists.

What this means for exhibitors

Exhibitors may explain intended use, evidence, technical specifications and regulatory status to a clinically informed audience. The broad French medtech turnover figure is context, not proof of aesthetic-device demand; product fit, conformity, clinical evidence and commercial terms remain important barriers.

What this means for visitors

Visitors may compare technology against clinical requirements and request documentation for review after the congress. France’s broad medtech base provides context, but without an aesthetic-device demand estimate, sourcing and investment decisions should rely on product-level evidence rather than the sector total.